Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 27:8:60.
doi: 10.12688/gatesopenres.15569.2. eCollection 2024.

Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration

E Wangeci Kagucia  1   2 , Shirine Voller  1   3 , Abdhalah K Ziraba  4 , Godfrey Bigogo  5 , Patrick K Munywoki  6 , Kimani Makobu  1 , D James Nokes  1   7 , James Nyagwange  1 , Cameline Orlendo  1 , Donald Akech  1 , Antipa Sigilai  1 , Clayton Onyango  6 , Bonventure Juma  6 , Amy Herman-Roloff  6 , Peninah Munyua  6 , Caroline Apondi  8 , Shirley Lidechi  5 , Allan Audi  5 , Alice Ouma  8 , George Aol  5 , Thomas Misore  5 , Caroline Nasimiyu  9   10 , Dickens Onyango  11 , Terrence Lo  6 , Kadondi Kasera  12 , Rose Jalang'o  12 , Leonard Kingwara  12 , Ifedayo Adetifa  1   3   13 , Anthony O Etyang  1   2 , George Warimwe  1   2 , Ambrose Agweyu  1   2   3 , J Anthony G Scott  1   2   3
Affiliations

Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration

E Wangeci Kagucia et al. Gates Open Res. .

Abstract

The Kenya Multi Site Serosurveillance (KEMIS) collaboration set out to implement an integrated, nationally representative, population-based program of serological surveillance for past infection for a number of important infectious diseases in Kenya. The project started in December 2021 and built on a portfolio of SARS-CoV-2 research conducted in 2020 and 2021. In this profile paper, we describe the background of the KEMIS collaboration, its aim and objectives, the Health and Demographic Surveillance System sites that were involved in data collection, and the key activities undertaken. We also explain how we established governance and management of the KEMIS collaboration, and reflect on opportunities, challenges, lessons learned, and future directions.

Keywords: COVID-19; HDSS; Kenya; SARS-CoV-2; integrated serosurveillance; multiplex; national serosurveillance platform; partnership.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Geographical location of KEMIS HDSS sites.
Figure 2.
Figure 2.. KEMIS project management and governance.
See this image and copyright information in PMC

References

    1. Uyoga S, Adetifa IMO, Karanja HK, et al. : Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science. 2021;371(6524):79–82. 10.1126/science.abe1916 - DOI - PMC - PubMed
    1. Adetifa IMO, Uyoga S, Gitonga JN, et al. : Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya. Nat Commun. 2021;12(1): 3966. 10.1038/s41467-021-24062-3 - DOI - PMC - PubMed
    1. Etyang AO, Lucinde R, Karanja H, et al. : Seroprevalence of antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 among healthcare workers in Kenya. Clin Infect Dis. 2022;74(2):288–293. 10.1093/cid/ciab346 - DOI - PMC - PubMed
    1. Kagucia EW, Gitonga JN, Kalu C, et al. : Anti-Severe Acute Respiratory Syndrome Coronavirus 2 immunoglobulin G antibody seroprevalence among truck drivers and assistants in Kenya. Open Forum Infect Dis. 2021;8(7): ofab314. 10.1093/ofid/ofab314 - DOI - PMC - PubMed
    1. Etyang AO, Adetifa I, Omore R, et al. : SARS-CoV-2 seroprevalence in three Kenyan health and demographic surveillance sites, December 2020-May 2021. PLOS Glob Public Health. 2022;2(8): e0000883. 10.1371/journal.pgph.0000883 - DOI - PMC - PubMed

LinkOut - more resources